MAR 09, 2015 04:30 PM PDT

Stem Cell Researchers Develop Method to Treat Sickle Cell Disease

WRITTEN BY: Ilene Schneider
UCLA stem cell researchers have shown that a novel stem cell gene therapy method could lead to a one-time, lasting treatment for sickle cell disease-the nation's most common inherited blood disorder. Published in the journal Blood, the study led by Dr. Donald Kohn of the UCLA Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research outlines a method that corrects the mutated gene that causes sickle cell disease and shows, for the first time, that the gene correction method leads to the production of normal red blood cells.

People with sickle cell disease are born with a mutation in their beta-globin gene that causes blood stem cells-which are made in the bone marrow-to produce rigid red blood cells that resemble a crescent or 'sickle' shape. These abnormally shaped red blood cells do not move smoothly through blood vessels, resulting in insufficient oxygen to vital organs.

The stem cell gene therapy method described in the study seeks to correct the mutation in the beta-globin gene so bone marrow stem cells produce normal, circular-shaped blood cells. The technique used specially engineered enzymes, called zinc-finger nucleases, to eliminate the mutated genetic code and replace it with a corrected version that repairs the beta-globin mutation.

The research showed that the method holds the potential to permanently treat the disease if a higher level of correction is achieved.

"This is a very exciting result," said Dr. Kohn, professor of pediatrics and microbiology, immunology and molecular genetics. "It suggests the future direction for treating genetic diseases will be by correcting the specific mutation in a patient's genetic code. Since sickle cell disease was the first human genetic disease where we understood the fundamental gene defect, and since everyone with sickle cell has the exact same mutation in the beta-globin gene, it is a great target for this gene correction method."

(Source: UCLA)
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
DEC 06, 2019
Genetics & Genomics
DEC 06, 2019
Mutants Are Everywhere - You're One Too
As fathers age, they tend ot pass down more genetic mutations to their children....
DEC 06, 2019
Genetics & Genomics
DEC 06, 2019
Can Autism be Diagnosed from Blood Tests?
Diagnosing Autism Spectrum Disorder (ASD) early on in life through behavioral signs alone has been difficult. This comes as typical markers for the conditi...
DEC 06, 2019
Genetics & Genomics
DEC 06, 2019
How Liquid Biopsies Can Teach Us About Cancer Drug Resistance
Cancer patients often endure challenging treatment courses to shrink their tumors, but the tumors can make a powerful comeback....
DEC 06, 2019
Genetics & Genomics
DEC 06, 2019
Membrane-less Organelle Found to Play a Role in Preventing Cancer
In recent years, scientists have found that a phenomenon called phase separation plays a critical role in the functions of cells....
DEC 06, 2019
Genetics & Genomics
DEC 06, 2019
Why is Some Chicken So Chewy? Researchers Have an Answer
Some broiler chickens suffer from wooden breast syndrome, which causes their meat to turn chewy and hard. Birds with this disorder can't be sold....
DEC 06, 2019
Genetics & Genomics
DEC 06, 2019
Engineering a Better Viral Delivery System for Gene Therapy
To send gene therapy to diseased cells, scientists have turned to adeno-associated viruses (AAVs) to act as a delivery system....
Loading Comments...